levodopa 42 MG Inhalation Powder [Inbrija]
RxNorm concept 2107621, branded drug (sbd). Prescribable name: Inbrija 42 MG Inhalation Powder Capsule.
- RxCUI
- 2107621
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2107621 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Inbrija 42 MG Inhalation Powder; L-DOPA 42 MG Inhalation Powder [Inbrija]
Related concepts
- levodopa 42 MG (SCDC, consists of)
- levodopa 42 MG [Inbrija] (SBDC, consists of)
- Inhalation Powder (DF, has dose form)
- Inbrija (BN, has ingredient)
- levodopa 42 MG Inhalation Powder (SCD, tradename of)
Linked data
NDCs
- 00259614201
- 00259614216
- 00259614232
- 00259614260
- 10144034201
- 10144034204
- 10144034212
- 10144034216
- 10144034232
- 10144034260
- 10144034292
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2107621 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2107621 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2107621. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.